RIO DE JANEIRO, BRAZIL - Cuba said on Monday, June 21, that its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.
The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses.
"Hit by the pandemic, our scientists at the Finlay Institute and Center for Genetic Engineering and Biotechnology have risen above all the obstacles and given us two very effective vaccines," President Miguel Diaz-Canel tweeted.
The announcement came from state-run biopharmaceutical corporation BioCubaFarma, which oversees . . .